Zhongguancun Science Park (Z-Park) saw swift industrial growth in the biomedicine sector by the end of August, local media reported on September 26, 2018. Biomedicine key to Zhongguancun sub-park In the first eight months of 2018, the biomedicine industry of Zhongguancun Miyun Park generated tax revenues of about 315 million yuan ($46 million) and contributed nearly 82 million yuan to the fiscal revenue of Beijing's Miyun district. The figures were respectively up by 81% and 76%, compared with the same period in 2017. The sub-park of Z-Park has been making full use of its environment’s resources and doubling down on the quality of development of biomedicine enterprises. Currently there are 26 large biomedicine companies headquartered in the area. Many of them are listed on stock markets in the Chinese mainland and Hong Kong. They are committed to developing anti-tumor products, time-release preparations, medical equipment and traditional Chinese medicine.

Source: Chinadaily